Bladder lining signals and bladder problems in type 2 diabetes
Role of Urothelial Purinergic Signaling in Diabetic Bladder Dysfunction
['FUNDING_R01'] · UNIVERSITY OF NEVADA RENO · NIH-11048876
Researchers are looking at whether changes in chemical signals from the bladder lining cause bladder control problems in people with type 2 diabetes.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF NEVADA RENO (nih funded) |
| Locations | 1 site (RENO, UNITED STATES) |
| Trial ID | NIH-11048876 on ClinicalTrials.gov |
What this research studies
From my perspective as a patient, the team studies how the bladder's lining cells release and break down chemicals (like ATP and adenosine) that control bladder function. Most work is done in two mouse models of type 2 diabetes to measure these purine signals in the bladder wall and to see how membrane channels, enzymes, and nerve-related molecules change that signaling. They will map where the enzymes are released and how mechanical forces affect chemical breakdown in the bladder tissue. The goal is to find biological steps that could be targeted to ease bladder problems seen with diabetes without the side effects of current muscle-focused drugs.
Who could benefit from this research
Good fit: Adults with type 2 diabetes who have bladder symptoms such as poor bladder emptying, reduced bladder sensation, or large-volume underactive bladder are the most relevant group.
Not a fit: People whose bladder problems come from non-diabetic causes (like anatomic blockage, spinal cord injury, or primary neurologic disease) are unlikely to benefit directly from these findings.
Why it matters
Potential benefit: If successful, this could point to new treatments that improve diabetic bladder control by fixing chemical signaling in the bladder lining with fewer side effects.
How similar studies have performed: Prior animal and pilot work has shown altered ATP and adenosine levels in diabetic bladders, so the approach builds on promising basic findings but still needs translation to human treatments.
Where this research is happening
RENO, UNITED STATES
- UNIVERSITY OF NEVADA RENO — RENO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUTAFOVA-YAMBOLIEVA, VIOLETA N. — UNIVERSITY OF NEVADA RENO
- Study coordinator: MUTAFOVA-YAMBOLIEVA, VIOLETA N.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus